NHS won’t get cutting-edge drugs unless it pays more, says AstraZeneca boss
Pascal Soriot says cost-effectiveness thresholds for new medicines have not changed for two decades Business live – latest updates The boss of AstraZeneca has said that unless the UK ramps up spending on new drugs, it could be on a trajectory to only being able to afford cheap, generic medicines (…)
Site référencé:
The Guardian (South&CentralAsia)
5413.jpg?width=140&quality=85&auto=format&fit=max&s=7e243059ae2ace21bbd25679f1a8e314, 5413.jpg?width=460&quality=85&auto=format&fit=max&s=698d170124b9c9a17f51cab99e3a6dc2, 5413.jpg?width=700&quality=85&auto=format&fit=max&s=57ad5df4e5c394a098bfc5a949ed579c
The Guardian (South&CentralAsia)
Marks & Spencer’s cyber-trauma is bad, but clearly manageable
5/11/2025
More reading tests won’t help children improve their literacy – here’s what will | Letters
5/11/2025
Tackling the democracy deficit in schools | Letter
5/11/2025
End-of-life care needs a fundamental review, not just more funding | Letters
5/11/2025
We need to restore Britain’s connection to nature | Letter
5/11/2025
UK opts out of flagship fund to protect Amazon and other threatened tropical forests
5/11/2025